<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Chemistry</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/904E261F-3A39-4BA2-AD41-A061C8D34E2F"><gtr:id>904E261F-3A39-4BA2-AD41-A061C8D34E2F</gtr:id><gtr:name>Oxford Nanopore Technologies</gtr:name><gtr:address><gtr:line1>Edmund Cartwright House</gtr:line1><gtr:line2>4 Robert Robinson Avenue</gtr:line2><gtr:line3>Oxford Sciences Park</gtr:line3><gtr:postCode>OX4 4GA</gtr:postCode><gtr:region>Unknown</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/1C8AE266-693C-4F44-A10E-9135261F31F5"><gtr:id>1C8AE266-693C-4F44-A10E-9135261F31F5</gtr:id><gtr:firstName>Stefan</gtr:firstName><gtr:surname>Howorka</gtr:surname><gtr:orcidId>0000-0002-6527-2846</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=EP%2FN009282%2F1"><gtr:id>87884FAC-888F-49EE-995E-0348DA9571D2</gtr:id><gtr:title>Minimal DNA Nanopores for Electrical Sensing of Proteins</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/N009282/1</gtr:grantReference><gtr:abstractText>Proteins are of paramount importance in our lives. They carry out the main functions in our bodies and control our movement, energy conversion, immune defence, and thinking. In medicine, functionally aberrant proteins cause disease. The proteins can, however, be targeted by drugs to cure cells. Enzymes are also of biotechnological importance in the cost-efficient synthesis of drug molecules or for the energy-saving cleaning of fabrics.

Detecting and analysing proteins is the first step towards predicting diseases, developing cures, and engineering proteins for industry. The analysis of proteins improves our understanding their structure, dynamics, and function. Ideally, sensing of proteins should be simple and fast and be conducted using inexpensive and portable equipment. This increase research efficiency and opens up point-of-care sensing in diagnosis and homeland security.

This project will provide a new way to sense proteins in a portable yet scientifically accurate fashion thereby overcoming problems of existing approaches. Classical approaches have issues such as the requirement to label the proteins with a fluorescent tag which can interfere with the structure and function of the proteins. Optical detection can also increase the weight and cost of the analytical device. Another limitation of conventional sensing approaches is that they average over millions of molecules and have difficulties to detect biologically important sub-groups.

We will develop a new approach to sense proteins in a label and optics-free electrical fashion using portable equipment capable of uncovering proteins down to the level of individual molecules. The proposed strategy is currently being used for DNA strand sequencing. Our industry partner Oxford Nanopore Technologies has developed a hand-held device for genome sequencing. The analytes are detected when individual strands pass through nanoscale pores in a thin membrane. The temporary blockade of the pores alters the electronic read-out signal similar to the reduction of water flow when a stone is inside a tube. 

We will be able to sense proteins which are wide enough to accommodate proteins. The new pores will be composed of DNA stands, thereby exploiting the exquisite ability of DNA to function as a nanoscale construction material. Chemical modification will be key to achieve the functional performance of the pores. To maximise the benefit for academia, industry and society, we will strongly collaborate with our commercial partner to test the new pores in the portable electrical sensing devices.</gtr:abstractText><gtr:potentialImpactText>The project will generate biosensor components composed of DNA nanopores which will enable the electrical and label-free sensing of proteins of biomedical or biosafety relevance in research and in point-of-care settings.

The first impact of DNA nanopores will be in basic science and single-molecule research. By enabling label-free real-time sensing in solution, the approach will avoid the drawbacks of other competing strategies which require fluorescence labeling or immobilization at an inorganic surface (AFM) which can interfere with the protein's natural confirmation. The nanopore approach is compatible with a wide range of analytes including enzymes, signaling proteins, and immune-relevant proteins. The DNA nanopores are termed minimal as they are reduced to the essential functional parts.

The second impact will be in diagnostic sensing using devices from industry partner Oxford Nanopore Technologies. DNA nanopores can expand the scope of analytes detected with electrical sensing to biomedically relevant proteins including immunoproteins or enzymes that interact with drugs. The collaboration with ONT will ensure that the nanopores will be tested in state-of-the-art analysis platforms. Feedback will be provided on the performance of the DNA nanopores in commercial biosensing.

The proposal is, thrid, of national importance as it will strengthen the industrial base by helping develop new sensor components for companies such as ONT. By expanding the scope of nanopore sensing, the proposal will also add to UK's academic and economic strength in this area.</gtr:potentialImpactText><gtr:fund><gtr:end>2019-01-10</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2016-01-11</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>405367</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The project has generated DNA nanopores that are wide enough to accommodate proteins. This is an advancement compared to previously developed DNA pores. The wider DNA nanopores address a need which is currently unmet and can be used by industry partner Oxford Nanopore Technologies (see below).</gtr:description><gtr:exploitationPathways>The DNA nanopores developed in this project can be used by collaborating company Oxford Nanopore Technologies as components in their portable sensors technology to detect diagnostically relevant proteins.</gtr:exploitationPathways><gtr:id>4F1CD3AB-A88D-455A-8BD4-A702A4DE153B</gtr:id><gtr:sectors><gtr:sector>Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://howorkalab.com</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3392D71D-D2EC-40F9-8297-7FC21F5360C7"><gtr:id>3392D71D-D2EC-40F9-8297-7FC21F5360C7</gtr:id><gtr:title>Nanopores and Nanochannels: From Gene Sequencing to Genome Mapping.</gtr:title><gtr:parentPublicationTitle>ACS nano</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/11417e87ad7b3cbdb2664a6289fd1b52"><gtr:id>11417e87ad7b3cbdb2664a6289fd1b52</gtr:id><gtr:otherNames>Howorka S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1936-0851</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3D1D2364-E243-4D20-BB6C-EA0A04F365AF"><gtr:id>3D1D2364-E243-4D20-BB6C-EA0A04F365AF</gtr:id><gtr:title>Biomimetic Hybrid Nanocontainers with Selective Permeability.</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie (International ed. in English)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/69407ad0a2c380502a9bce6f839717a7"><gtr:id>69407ad0a2c380502a9bce6f839717a7</gtr:id><gtr:otherNames>Messager L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1433-7851</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2DC0D821-264B-438B-BF12-289C86B77BE8"><gtr:id>2DC0D821-264B-438B-BF12-289C86B77BE8</gtr:id><gtr:title>Biomimetic Hybrid Nanocontainers with Selective Permeability</gtr:title><gtr:parentPublicationTitle>Angewandte Chemie</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/69407ad0a2c380502a9bce6f839717a7"><gtr:id>69407ad0a2c380502a9bce6f839717a7</gtr:id><gtr:otherNames>Messager L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/N009282/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>F442B6BE-8B89-4C01-8D3B-E8A4D320B672</gtr:id><gtr:percentage>40</gtr:percentage><gtr:text>Biomolecules &amp; biochemistry</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>863FC58A-7217-42EA-B076-663F2D770BB8</gtr:id><gtr:percentage>40</gtr:percentage><gtr:text>Chemical measurement</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>60EBB420-734E-4DB5-B0F2-65A1115A27F8</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Chemical synthesis</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>98EA7556-1427-44F9-84F3-BF99B7207302</gtr:id><gtr:percentage>40</gtr:percentage><gtr:text>Analytical Science</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>02FE9751-1497-4DFD-B349-D4A9C96538E1</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Biophysics</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>02567418-12CB-462E-9092-530C6E63B359</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Chemical Biology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>454398F2-57A6-4959-8845-0F248CF4D5C4</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Chemical Synthetic Methodology</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>